MetaRing quickly identifies breast cancer drug sensitivity

by Hefei Institutes of Physical Science, Chinese Academy of SciencesSchematic illustration of the MetaRing platform for detecting paclitaxel treatment sensitivity in breast cancer. Credit: HUANG Guang

Updated on: April 27,2026

MetaRing quickly identifies breast cancer drug sensitivity

by Hefei Institutes of Physical Science, Chinese Academy of SciencesSchematic illustration of the MetaRing platform for detecting paclitaxel treatment sensitivity in breast cancer. Credit: HUANG Guang

Updated on:April 27,2026

New study elucidates obesity's role in fueling breast cancer progression

byElsevierNew research inThe American Journal of Pathologyclarifies the role of obesity in fueling breast cancer progression by identifying the leptin-SCD pathway as a key driver of metabolic and func

Updated on: March 20,2026

New study elucidates obesity's role in fueling breast cancer progression

byElsevierNew research inThe American Journal of Pathologyclarifies the role of obesity in fueling breast cancer progression by identifying the leptin-SCD pathway as a key driver of metabolic and func

Updated on:March 20,2026

Tracking RNA levels reveals new clues in triple-negative breast cancer progression

by Jen A. Miller,Cold Spring Harbor LaboratoryMetastatic lesions had far higher levels ofMALAT1(pink) than the surrounding tissues. Credit: Spector lab/CSHLWhen researchers look for potential cancer t

Updated on: April 04,2026

Tracking RNA levels reveals new clues in triple-negative breast cancer progression

by Jen A. Miller,Cold Spring Harbor LaboratoryMetastatic lesions had far higher levels ofMALAT1(pink) than the surrounding tissues. Credit: Spector lab/CSHLWhen researchers look for potential cancer t

Updated on:April 04,2026

Macrophage 'bodyguard' disruptors may help overcome hormone-resistant breast cancer

byUniversity of Miami Leonard M. Miller School of Medicine"This triple therapy approach could be a game-changer for patients whose (breast) cancers no longer respond to standard hormone treatment

Updated on: March 14,2026

Macrophage 'bodyguard' disruptors may help overcome hormone-resistant breast cancer

byUniversity of Miami Leonard M. Miller School of Medicine"This triple therapy approach could be a game-changer for patients whose (breast) cancers no longer respond to standard hormone treatment

Updated on:March 14,2026

FDA warns biotech firm over cancer drug claims

by HealthDay StaffThe U.S. Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cancer.The agency sent a

Updated on: April 22,2026

FDA warns biotech firm over cancer drug claims

by HealthDay StaffThe U.S. Food and Drug Administration (FDA) has warned a biotech company about claims that its bladder cancer drug could treat and prevent multiple types of cancer.The agency sent a

Updated on:April 22,2026

Custom 3D-printed models improve precision of oral cancer removal

byOhio State University Medical CenterThis 3D model of a patient's jaw was created by doctors at The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J

Updated on: February 13,2026

Custom 3D-printed models improve precision of oral cancer removal

byOhio State University Medical CenterThis 3D model of a patient's jaw was created by doctors at The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J

Updated on:February 13,2026

Ultrasound paired with vibrating nanoparticles softens tumor tissue, improving drug delivery

byUniversity of Colorado at BoulderA microscopic image of the researchers' sound-responsive particles. Credit: Andrew Goodwin/University of Colorado BoulderCancer is one of the leading causes of d

Updated on: April 06,2026

Ultrasound paired with vibrating nanoparticles softens tumor tissue, improving drug delivery

byUniversity of Colorado at BoulderA microscopic image of the researchers' sound-responsive particles. Credit: Andrew Goodwin/University of Colorado BoulderCancer is one of the leading causes of d

Updated on:April 06,2026

Multiple myeloma develops differently in men and women, study reveals

by Candace Gwaltney,Indiana UniversitySummary of key findings. Credit:Blood Cancer Journal(2025). DOI: 10.1038/s41408-025-01362-1Researchers at the Indiana University Melvin and Bren Simon Comprehensi

Updated on: March 16,2026

Multiple myeloma develops differently in men and women, study reveals

by Candace Gwaltney,Indiana UniversitySummary of key findings. Credit:Blood Cancer Journal(2025). DOI: 10.1038/s41408-025-01362-1Researchers at the Indiana University Melvin and Bren Simon Comprehensi

Updated on:March 16,2026

Genomic test helps flag early aggressive prostate cancer in African American patients

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Anna Tarazevich from PexelsA new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men w

Updated on: February 26,2026

Genomic test helps flag early aggressive prostate cancer in African American patients

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Anna Tarazevich from PexelsA new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men w

Updated on:February 26,2026

Lung cancer's earliest stages may be driven by inflammation

byUniversity of Texas MD Anderson Cancer CenterSpatial transcriptomics analysis with super-pixel resolution of a human lung precursor lesion (red dash border), with colors representing different gene

Updated on: March 13,2026

Lung cancer's earliest stages may be driven by inflammation

byUniversity of Texas MD Anderson Cancer CenterSpatial transcriptomics analysis with super-pixel resolution of a human lung precursor lesion (red dash border), with colors representing different gene

Updated on:March 13,2026

HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model

by Society of Nuclear Medicine and Molecular ImagingGraphical Abstract: Schematic representation of 3-step HER2-targeted225Ac-PRIT,225Ac-PRIT treatment of BT-474 human breast cancer cell derived xenog

Updated on: March 04,2026

HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model

by Society of Nuclear Medicine and Molecular ImagingGraphical Abstract: Schematic representation of 3-step HER2-targeted225Ac-PRIT,225Ac-PRIT treatment of BT-474 human breast cancer cell derived xenog

Updated on:March 04,2026

uPAR-targeted CAR T cells shrank solid tumors and cleared metastases in mice

byMemorial Sloan Kettering Cancer CenterCredit:Cell(2026). DOI: 10.1016/j.cell.2026.03.002Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers li

Updated on: May 20,2026

uPAR-targeted CAR T cells shrank solid tumors and cleared metastases in mice

byMemorial Sloan Kettering Cancer CenterCredit:Cell(2026). DOI: 10.1016/j.cell.2026.03.002Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers li

Updated on:May 20,2026